521 related articles for article (PubMed ID: 23425294)
1. Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.
Garris C; Jhingran P; Bass D; Engel-Nitz NM; Riedel A; Dennis G
J Med Econ; 2013; 16(5):667-77. PubMed ID: 23425294
[TBL] [Abstract][Full Text] [Related]
2. Impact of early versus late systemic lupus erythematosus diagnosis on clinical and economic outcomes.
Oglesby A; Korves C; Laliberté F; Dennis G; Rao S; Suthoff ED; Wei R; Duh MS
Appl Health Econ Health Policy; 2014 Apr; 12(2):179-90. PubMed ID: 24573911
[TBL] [Abstract][Full Text] [Related]
3. Economic outcomes in patients diagnosed with systemic lupus erythematosus with versus without nephritis: results from an analysis of data from a US claims database.
Pelletier EM; Ogale S; Yu E; Brunetta P; Garg J
Clin Ther; 2009 Nov; 31(11):2653-64. PubMed ID: 20110008
[TBL] [Abstract][Full Text] [Related]
4. Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.
Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
J Med Econ; 2013; 16(4):500-9. PubMed ID: 23363329
[TBL] [Abstract][Full Text] [Related]
5. Healthcare utilization and costs among chronic bronchitis patients treated with maintenance medications from a US managed care population.
AbuDagga A; Sun SX; Tan H; Solem CT
J Med Econ; 2013; 16(3):421-9. PubMed ID: 23336296
[TBL] [Abstract][Full Text] [Related]
6. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
7. Flare frequency, healthcare resource utilisation and costs among patients with gout in a managed care setting: a retrospective medical claims-based analysis.
Jackson R; Shiozawa A; Buysman EK; Altan A; Korrer S; Choi H
BMJ Open; 2015 Jun; 5(6):e007214. PubMed ID: 26109113
[TBL] [Abstract][Full Text] [Related]
8. Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population.
Amonkar MM; Chastek B; Samant N; Teitelbaum A
J Med Econ; 2011; 14(4):421-32. PubMed ID: 21619455
[TBL] [Abstract][Full Text] [Related]
9. Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population.
Furst DE; Clarke A; Fernandes AW; Bancroft T; Gajria K; Greth W; Iorga SR
Lupus; 2013 Mar; 22(3):268-78. PubMed ID: 23340996
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
[TBL] [Abstract][Full Text] [Related]
11. Costs associated with severe and nonsevere systemic lupus erythematosus in Canada.
Clarke AE; Urowitz MB; Monga N; Hanly JG
Arthritis Care Res (Hoboken); 2015 Mar; 67(3):431-6. PubMed ID: 25185936
[TBL] [Abstract][Full Text] [Related]
12. A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus.
Kan H; Guerin A; Kaminsky MS; Yu AP; Wu EQ; Denio A; Priti J; Narayanan S; Molta C
J Med Econ; 2013; 16(6):793-800. PubMed ID: 23647447
[TBL] [Abstract][Full Text] [Related]
13. Disease severity and economic burden in Japanese patients with systemic lupus erythematosus: A retrospective, observational study.
Tanaka Y; Mizukami A; Kobayashi A; Ito C; Matsuki T
Int J Rheum Dis; 2018 Aug; 21(8):1609-1618. PubMed ID: 30146745
[TBL] [Abstract][Full Text] [Related]
14. Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Saiers J; Serrano D; Reed ML
J Med Econ; 2013; 16(4):490-9. PubMed ID: 23356422
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
Miyazaki C; Sruamsiri R; Mahlich J; Jung W
J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
[No Abstract] [Full Text] [Related]
16. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
[TBL] [Abstract][Full Text] [Related]
17. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis.
Divino V; Dekoven M; Warner JH; Giuliano J; Anderson KE; Langbehn D; Lee WC
J Med Econ; 2013 Aug; 16(8):1043-50. PubMed ID: 23789925
[TBL] [Abstract][Full Text] [Related]
18. One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.
Burton TM; Lacey M; Liu F; Yu Y; Monsalvo ML; Lang K; Sander S
J Med Econ; 2012; 15(6):1217-25. PubMed ID: 22857539
[TBL] [Abstract][Full Text] [Related]
19. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
[TBL] [Abstract][Full Text] [Related]
20. Healthcare costs of pregnancy in systemic lupus erythematosus: retrospective observational analysis from a US health claims database.
Petri M; Daly RP; Pushparajah DS
J Med Econ; 2015; 18(11):967-73. PubMed ID: 26121160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
